Multiple Cohorts Link Short Sleep Duration to Lower Testosterone in Men
Cohort and Experimental Data Link Short Sleep to Lower Testosterone in Men
Read More →
Policy Analysis
Heart Disease in Men: Answering Common Questions from Latest CDC Reports
What do CDC and MMWR data reveal about cardiovascular risk factors in men?
More stories
FDA Clarifies Regulatory Expectations for AI Tools in Heart Disease Prevention
FDA Issues Draft Guidance on AI/ML Software for Cardiovascular Risk Assessment
Read More →FDA Clarifies Regulatory Expectations for Software Monitoring Cardiovascular and Metabolic Parameters in Men
FDA Clarifies Regulatory Expectations for Digital Health Technologies in Remote Physiologic Monitoring
Read More →What Large-Scale NIH Wearables Cohort Data Show About Early Detection in Men
NIH-Funded Wearable Device Studies Link Continuous Metrics to Cardiovascular Risk Models for Men
Read More →What Registry Data Show About Emerging Digital Prevention Approaches for Men's Heart Health
NIH-Funded Research Examines Digital Tools for Cardiovascular Risk Monitoring in Men
Read More →Synthesis of RCTs Shows Modest Improvements in Blood Pressure and Glucose from Wearable Trackers in Men
Synthesis of Trials Links Wearable Trackers to Modest Step Gains and Select Cardiometabolic Shifts in Overweight Adults
Read More →Do stem cell creams and growth factor creams work for anti-aging?
We may earn a commission from links on this page.
Read More →What are the benefits of growth factor and stem cell serums for anti-aging?
Growth factor and stem cell serums, like the Factor Five Regenerative Serum, are designed to target wrinkles, sun spots, skin laxity, skin thickness, and uneven texture through topical application.
Read More →Pooled Trial Data Show No Significant Increase in Major Adverse Cardiovascular Events With Testosterone Therapy
TRAVERSE Trial Reports No Rise in Major Adverse Cardiovascular Events With Testosterone Replacement Therapy
Read More →FDA Authorizes Reformulated mRNA COVID-19 Vaccines for 2024-2025 Season
FDA Authorizes Updated 2024-2025 COVID-19 Vaccines Targeting KP.2 Variant
Read More →What Primary NIH and PMC Studies Show About Digital Wellness Tools in Men's Heart Health Prevention
NIH-Funded Research Links Wearable Devices to Atrial Fibrillation Detection and Cardiovascular Risk Tracking in Men
Read More →USPSTF Prostate Cancer Screening Recommendations: Evidence-Based Questions and Official Answers
The U.S. Preventive Services Task Force set its current standards for PSA-based prostate cancer screening in a 2018 final recommendation statement. The task force assigned a Grade C to the practice for men ages 55 to 69
Read More →FDA Clarifies Oversight of Software and Devices Marketed for Digital Wellness Tracking
FDA Guidance Excludes Low-Risk Wellness Technologies From Medical Device Regulation
Read More →What Multiple Prospective Cohorts Reveal About Exercise Volume and Prostate Cancer Incidence in Men
Cohort Studies Link Higher Physical Activity to Lower Risk of Advanced Prostate Cancer
Read More →How do you build an effective anti-aging skincare routine for different ages, skin types, and concerns?
Collagen production starts dropping in your mid-20s, and visible changes like wrinkles, sun spots, and skin laxity speed up after age 30.
Read More →CDC Issues Risk-Based Guidance on RSV Vaccines for Adults 60 and Older
The CDC updated its guidance on RSV vaccination for older adults. The agency moved from a shared clinical decision making model for all adults 60 and older to defined criteria based on age and specific health risks. This
Read More →CDC Issues Shared Clinical Decision-Making Guidance for RSV Vaccines in Older Adults
CDC Updates RSV Vaccine Recommendations for Adults Aged 60 and Older
Read More →Heart Disease in Men: Answering Common Questions Using Latest CDC Reports
CDC and MMWR Data Show High Rates of Cardiovascular Risk Factors in Middle-Aged U.S. Men
Read More →FDA Clears Dexcom Stelo as First OTC CGM for Adults 18 and Older Not Using Insulin
FDA Clears First Over-the-Counter Continuous Glucose Monitor
Read More →FDA Warns of Hidden Ingredients in Online Erectile Dysfunction Products
FDA Updates Tracking of Tainted Sexual Enhancement Products Containing Undeclared PDE5 Inhibitors
Read More →Cardiovascular Risk in Men: Answering Common Questions Using Latest CDC and NIH Reports
CDC and NIH Data Show High Prevalence of Cardiovascular Risk Factors Among U.S. Men Aged 40-59
Read More →FDA Clearance Pathways and AHA Statements on Consumer Wearables for Heart Health Monitoring
FDA Clearance Pathways and AHA Statements on Consumer Wearables for Heart Health Monitoring
Read More →What Multiple Large Trials Show About Heart Risks in Men Using TRT
What Multiple Large Trials Show About Heart Risks in Men Using TRT
Read More →FDA Warns of Hidden PDE5 Inhibitors and Anabolic Steroids in Over-the-Counter Male Supplements
FDA Warns of Hidden PDE5 Inhibitors and Anabolic Steroids in Over-the-Counter Male Supplements
Read More →Which night face cream is best for glowing skin, firming, whitening, and overall results?
Recent analyses of dermatological trials and consumer trend reports reveal that night creams combining 0.25% retinol with stem-cell-derived growth factors deliver the most comprehensive improvements in skin radiance, firmness, even tone, and texture.
Read More →What is the best anti-aging wrinkle cream for women over 50?
No single cream universally qualifies as the best anti-aging wrinkle cream for women over 50, but the strongest published evidence points to retinoid-based formulas for measurable wrinkle reduction.
Read More →FDA Warns of Dosing Errors and Adverse Events Linked to Compounded Semaglutide
FDA Alerts Providers to Adverse Events and Dosing Errors Associated With Compounded Semaglutide
Read More →What Peer-Reviewed Evidence Shows About Wearables and Cardiometabolic Outcomes in Men
2022–2024 Studies Link Wearable Devices to Modest Increases in Physical Activity and Atrial Fibrillation Detection in Middle-Aged Men
Read More →FDA Clarifies Regulatory Expectations for AI-Driven Digital Wellness Interventions
FDA Clarifies Regulatory Expectations for AI-Driven Digital Wellness Interventions
Read More →Meta-Analysis of Resistance Training Frequency and Visceral Adipose Tissue Changes in Men Aged 40–65
Meta-Analysis of Resistance Training Frequency and Visceral Adipose Tissue Changes in Men Aged 40–65
Read More →What Primary Sources Show About Wearables in Men's Heart Health Prevention
What Primary Sources Show About Wearables in Men's Heart Health Prevention
Read More →FDA Warns of Undeclared PDE5 Inhibitors in OTC Male Enhancement Products
FDA Warns of Undeclared PDE5 Inhibitors in OTC Male Enhancement Products
Read More →Q&A: Current USPSTF Guidance on PSA-Based Prostate Cancer Screening for Men
Q&A: USPSTF Guidance on PSA-Based Prostate Cancer Screening for Men
Read More →How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
How the FDA Classifies and Reviews Digital Tools for Wellness Tracking
Read More →FDA Revises Labeling and Monitoring Guidance for GLP-1 Drugs Used in Type 2 Diabetes and Weight Management
FDA Updates Postmarket Safety Monitoring Requirements for GLP-1 Receptor Agonists
Read More →What Pooled Trial Data Show About Digital Fitness Trackers and Men's Heart Health
What Pooled Trial Data Show About Digital Fitness Trackers and Men's Heart Health
Read More →What Peer-Reviewed Literature Says About Consumer Wearables and Heart Health Metrics in Male Populations
Recent PMC Studies Evaluate Wearable Devices for Cardiovascular Risk Monitoring in Men
Read More →FDA Outlines Regulatory Framework for AI Tools Used in Preventive Cardiac Monitoring
FDA Outlines Regulatory Framework for AI Tools Used in Preventive Cardiac Monitoring
Read More →Large-Scale Analyses Associate Higher Physical Activity Levels With Lower Mortality in Men
Large-Scale Analyses Associate Higher Physical Activity Levels With Lower Mortality in Men
Read More →FDA Mandates Revised Cardiovascular and Prostate Cancer Risk Information in Testosterone Therapy Labeling
FDA Requires Updated Safety Labeling for Testosterone Replacement Therapy Products
Read More →FDA Revises Labels on GLP-1 Drugs with New Cardiovascular Risk Reduction Information
FDA Revises Labels on GLP-1 Drugs with New Cardiovascular Risk Reduction Information
Read More →Multiple Independent Cohorts Link Regular Resistance Exercise to Lower Visceral Adiposity and Improved Metabolic Profiles in Men Aged 40–65
Multiple Independent Cohorts Link Regular Resistance Exercise to Lower Visceral Adiposity and Improved Metabolic Profiles in Men Aged 40–65
Read More →Q&A: FDA-Authorized Digital Therapeutics for Anxiety and Depression – What the Primary Documents Show
Q&A: FDA-Authorized Digital Therapeutics for Anxiety and Depression – What the Primary Documents Show
Read More →FDA Highlights Post-Approval Cardiovascular and Gastrointestinal Data for Semaglutide
FDA Highlights Post-Approval Cardiovascular and Gastrointestinal Data for Semaglutide
Read More →FDA Detects Hidden Prescription Ingredients in Over-the-Counter Male Sexual Enhancement Products
FDA Detects Hidden Prescription Ingredients in Over-the-Counter Male Sexual Enhancement Products
Read More →FDA Clarifies Regulatory Expectations for AI Tools Used in Heart Disease Prevention
FDA Clarifies Regulatory Expectations for AI Tools Used in Heart Disease Prevention
Read More →FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
FDA Implements New Regulatory Framework for Lab-Developed Tests After Years of Debate
Read More →CDC Updates Advisory Committee Recommendations for Influenza Vaccination Coverage
CDC Updates Advisory Committee Recommendations for Influenza Vaccination Coverage
Read More →FDA Warns Consumers of Hidden Sildenafil and Tadalafil in Over-the-Counter Male Sexual Enhancement Products
FDA Warns Consumers of Hidden Sildenafil and Tadalafil in Over-the-Counter Male Sexual Enhancement Products
Read More →FDA Warns of Dosing Errors and Adverse Events Linked to Compounded GLP-1 Receptor Agonists
FDA Warns of Dosing Errors and Adverse Events Linked to Compounded GLP-1 Receptor Agonists
Read More →FDA Alerts Consumers to Adverse Events Linked to Compounded GLP-1 Receptor Agonists
FDA Alerts Consumers to Adverse Events Linked to Compounded GLP-1 Receptor Agonists
Read More →What Peer-Reviewed Literature Shows About Resistance Training and Testosterone Levels
What Peer-Reviewed Literature Shows About Resistance Training and Testosterone Levels
Read More →FDA Clarifies Regulatory Expectations for AI-Powered Digital Health Tools
FDA Clarifies Regulatory Expectations for AI-Powered Digital Health Tools
Read More →Meta-Analyses of Semaglutide Trials Report Differential Cardiovascular Risk Reduction Between Men and Women
Meta-Analyses of Semaglutide Trials Report Differential Cardiovascular Risk Reduction Between Men and Women
Read More →Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Q&A: Key Facts from CDC’s MMWR on Heart Disease in Men
Read More →Meta-Analyses Associate Evening Blue-Light Exposure With Altered Sleep and Lower Morning Testosterone
2023–2025 PubMed Studies Link Evening Blue Light Exposure to Melatonin Suppression, Altered Sleep Architecture, and 10–15 Percent Lower Testosterone in Men Aged 30–55
Read More →FDA Outlines Regulatory Expectations for AI-Driven Digital Tools in Primary Prevention of Heart Disease
FDA Outlines Regulatory Expectations for AI-Driven Digital Tools in Primary Prevention of Heart Disease
Read More →FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
FDA Detects Undeclared Sildenafil and Tadalafil in OTC Male Sexual Enhancement Products
Read More →Accuracy of Consumer Wearables for AFib Detection: What Peer-Reviewed Evidence Shows
Accuracy of Consumer Wearables for AFib Detection: What Peer-Reviewed Evidence Shows
Read More →CDC Report Details Age-Adjusted Cardiovascular Disease Prevalence and Modifiable Risk Factors in U.S. Men
CDC Report Details Age-Adjusted Cardiovascular Disease Prevalence and Modifiable Risk Factors in U.S. Men
Read More →Peer-Reviewed Studies Examine Accuracy of Consumer Wearables for Heart Rate, Blood Pressure, and Sleep Tracking in Adult Males
Validation Studies From 2022-2024 Report Accuracy Metrics for Wearable Heart Rate, Atrial Fibrillation Detection, and Sleep Tracking in Men
Read More →FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
FDA Outlines Regulatory Expectations for AI Tools Used in Heart Disease Prediction
Read More →What Pooled Primary Data Show About Consumer Wearables in Prevention Strategies
What Pooled Primary Data Show About Consumer Wearables in Prevention Strategies
Read More →Latest CDC Data Show Persistent Gaps in Men's Weekly Activity Meeting Federal Guidelines
Latest CDC Data Show Persistent Gaps in Men's Weekly Activity Meeting Federal Guidelines
Read More →CDC Data on Leading Heart Disease Risks for Men
CDC and MMWR Reports on Cardiovascular Risk Factors in Men
Read More →What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
What CDC and WHO Primary Reports State About Daily Sitting Time and Health Metrics
Read More →Wearable Trackers Linked to Modest Improvements in Activity and Metabolic Markers in Men, Literature Review Finds
Wearable Trackers Linked to Modest Improvements in Activity and Metabolic Markers in Men, Literature Review Finds
Read More →FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
FDA Clarifies Evidence Standards for Digital Tools Used in Remote Monitoring and Preventive Health
Read More →Published Trials Report Lean Mass Reductions Associated with GLP-1 Agonist Use in Men with Obesity
Published Trials Report Lean Mass Reductions Associated with GLP-1 Agonist Use in Men with Obesity
Read More →FDA Warns of Adverse Events Linked to Unapproved Compounded Versions of Ozempic and Wegovy
FDA Warns of Adverse Events Linked to Unapproved Compounded Versions of Ozempic and Wegovy
Read More →What Peer-Reviewed Evidence Shows About Strength Training and Hormonal Response
What Peer-Reviewed Evidence Shows About Strength Training and Hormonal Response
Read More →PubMed Analysis Tracks Growth of RCT Evidence on Wearable-Based Prevention Strategies for Men
PubMed Data Show Rise in Studies on Digital Wellness Interventions
Read More →FDA Regulatory Framework for Digital Health and Wellness Technologies
FDA Regulatory Framework for Digital Health and Wellness Technologies
Read More →What FDA Clearance Actually Means for Digital Mental Wellness Apps
What FDA Clearance Actually Means for Digital Mental Wellness Apps
Read More →Published Literature Examines Outcomes of Mobile Applications Targeting Anxiety, Depression, and Stress in Male Populations
Published Literature Examines Outcomes of Mobile Applications Targeting Anxiety, Depression, and Stress in Male Populations
Read More →FDA Proposes New Framework for Regulating AI in Consumer Digital Health Tools
FDA Proposes New Framework for Regulating AI in Consumer Digital Health Tools
Read More →